JMJames Michael Milburn

James Michael Milburn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


James Michael Milburn has a total of 226 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The productivity benchmark trap: how lagging survey data and selective blending compound CMS reimbursement cuts for employed neurointerventionalists

    by Clemens Maria Schirmer, Joshua A Hirsch, James M Milburn

    These instruments provide employers with a nationally referenced framework for setting wRVU productivity targets and calibrating compensation-per-wRVU rates. When administered and applied in a methodologically sound manner they serve a legitimate function in establishing fair market value and ensuring compliance with Stark Laws and the Anti-Kickback Statute.6 The wRVU is no longer a ‘stable currency’ due to a multiyear pattern of structural upward drift in survey benchmarks, a 2026 Centers for Medicare and Medicaid Services (CMS) policy shift that amplifies that drift, and employer blending practices that amplify the resulting distortions. For employed neurointerventionalists, the net effect is a compounding, structurally embedded disadvantage that accumulates with each successive fee schedule cycle.

  • Open Access

    Impact of intravenous thrombolysis on aspiration thrombectomy outcomes: an Imperative Trial subgroup analysis

    by Maxim Mokin, Reade Andrew De Leacy, William Mack, Raul G Nogueira, Shahram Majidi, Robert Dana Tomalty, Jan Vargas, Brett L Cucchiara, Kenneth V Snyder, Justin Mascitelli, et al.

    Background The impact of intravenous (IV) thrombolysis on the outcomes of aspiration thrombectomy as the primary endovascular approach to stroke in patients with large vessel occlusion is unknown. Methods The Imperative Trial was a prospective, investigational device exemption, multicenter trial of first-line aspiration thrombectomy that assessed the safety and efficacy of the Zoom System, including a novel 0.088 inch aspiration catheter in patients with stroke within 8 hours of onset. We compared procedural, technical, and clinical outcomes of aspiration thrombectomy based on whether patients had received IV thrombolytics prior to the intervention. Results Among the 260 patients treated with front-line aspiration thrombectomy using the Zoom System, 125 (48%) received IV thrombolysis prior to aspiration. Rates of modified Thrombolysis in Cerebral Infarction (mTICI) ≥2b achieved with the Zoom System were higher in the aspiration-only group than in the combined group (92% vs 81%, P=0.016). Rates of mTICI ≥2c and first pass effect were similar. The use of rescue devices to achieve mTICI ≥2b was less frequent in the aspiration-only group than in the combined group (2% vs 10%, P=0.008). The rates of functional independence (modified Rankin Scale (mRS) score 0–2) in the aspiration-only group and the combined group were 50% and 59%, respectively (P=0.16). Univariate (P=0.30) and multivariate (P=0.47) ordinal regression analyses showed no significant correlation of mRS 0–2 with IV thrombolysis. Both groups had similar safety outcomes including rates of symptomatic intracranial hemorrhage and 90-day mortality. Conclusions Aspiration thrombectomy alone may result in higher rates of successful reperfusion and reduce the need for rescue devices compared with the combined approach with IV thrombolysis.

  • Navigating the CY 2026 physician fee schedule: lessons from neurointerventional advocacy on CPT 61624 and 61626

    by Clemens M Schirmer, Melissa M Chen, James M Milburn, Guilherme Dabus, Joshua A Hirsch

  • Promises and Challenges of Medicare Advantage

    by Robert P. Frantz, James M. Milburn, Melissa M. Chen, Laxmaiah Manchikanti, Lauren P. Nicola, Joshua A. Hirsch

  • Open Access

    Diagnostic performance of neuroimaging modalities for epileptogenic focus localization: A systematic review

    by Mustafa S. Alhasan, Mohammed Khalil, Ayman S. Alhasan, Ahmed Najjar, Yasir Hassan Elhassan, Abdullah Almaghraby, Omar Alharthi, Seham Hamoud, Muhammed Amir Essibayi, Fabricio Feltrin, et al.

    Objective: Accurate localization of epileptogenic foci remains of significant importance for surgical planning in drug‐resistant epilepsy. Multiple neuroimaging modalities are available; however, their comparative diagnostic performance lacks comparative detailed synthesis. This systematic review aimed to evaluate and compare the diagnostic accuracy of structural MRI, PET imaging, SPECT/SISCOM, and combined multimodal strategies for epileptogenic focus localization. Methods: We conducted a systematic review following PRISMA 2020 guidelines, searching PubMed, Scopus, Google Scholar, Cochrane Library, and Web of Science databases up to May 30, 2025. Studies evaluating the diagnostic performance of neuroimaging modalities for epilepsy focus localization with surgical correlation were included. Data extraction focused on sensitivity, specificity, and clinical manner. Quality assessment used QUADAS‐2 criteria. Results: Fifteen studies included a total of 1157 patients that met inclusion criteria. Combined multimodal strategies integrating two or more imaging modalities demonstrated the highest diagnostic performance (sensitivity 82–100%), followed by structural MRI in lesional epilepsy (72–100% sensitivity). PET imaging showed consistent performance across clinical contexts (33–89% sensitivity), while SPECT/SISCOM exhibited variable results (33–83% sensitivity). Strong complementarity existed between MRI and PET (85% concordance), with context‐dependent optimization for lesional versus non‐lesional epilepsy. Significance: Combined multimodal neuroimaging provides superior diagnostic performance for epileptogenic focus localization. Clinical context significantly impacts the modality selection, with MRI prioritized in lesional cases and functional imaging essential for MRI‐negative epilepsy. These findings support evidence‐based imaging protocols for surgical epilepsy evaluation. Plain Language Summary: This systematic review evaluated which brain imaging techniques are best for finding the exact location where seizures start in people with drug‐resistant epilepsy who need surgery. The researchers analyzed 15 studies involving 1157 patients. They found that using multiple imaging techniques together (combining structural and functional imaging) provides the most accurate results, with success rates of 82–100%. Standard MRI scans work very well (72–100% accuracy) when there is a visible brain abnormality causing seizures. However, for patients whose MRI looks normal, additional functional imaging techniques like PET or SPECT scans are crucial, achieving 63–89% accuracy. The study shows that the best imaging approach depends on the individual patient's situation: MRI should be used first when a brain lesion is suspected, but functional imaging becomes essential when MRI does not show anything abnormal. These findings help doctors choose the right combination of imaging tests for each patient to improve surgical planning and outcomes.


  • Open Access

    Unseen wounds: a multinational investigation of neurointerventionalists on the psychological toll of complications

    by Ansaar T Rai, Emanuele Orru, Kyle M Fargen, Fabian Arnberg Sandor, Ricardo A Hanel, James M Milburn, Thanh N Nguyen, Nathan Farkas, Adam A Dmytriw, Adnan H Siddiqui

    Background Complications not only affect patients but also impose a significant psychological burden on physicians. Quantitative data in neurointerventional surgery regarding the ‘second victim’ phenomenon are lacking. This study aimed to assess the prevalence and severity of post-traumatic stress symptoms among neurointerventionalists after major complications. Methods A survey was developed by a committee of experienced neurointerventionalists and distributed internationally via multiple platforms. Respondents were anonymous. Demographic information, complication type, and institutional support availability were queried. Psychological distress was measured using the validated Impact of Event Scale-Revised (IES-R), which assesses intrusion, avoidance, and hyperarousal domains. Descriptive statistics and regression analyses were performed to identify factors associated with post-traumatic stress symptoms. Results Of 1042 invited physicians, 503 responded (48%), with 413 completing the full survey (40%). The most common pathology was cerebral aneurysm, and the most frequent complication was hemorrhage. Overall, 64% scored above the IES-R threshold for possible post-traumatic stress disorder (PTSD) (≥24), with many reaching levels (≥37) associated with long-term stress and physiological sequelae. Intrusion was the dominant symptom domain, particularly distressing reminders about the complication. Lack of institutional support was significantly associated with possible PTSD (OR 1.63, 95% CI 1.1 to 2.5, P=0.02). No differences were observed by specialty, but geographic variations were present. High stress scores persisted long after the index event. Conclusion Complications exert a profound emotional and physiological toll on neurointerventionalists, with high rates of possible PTSD and a strong association with inadequate institutional support. Systematic support programs are urgently needed to safeguard physician well-being and patient safety.


  • Open Access

    Medicare Advantage plans: who gets the advantage?

    by James M Milburn, Robert P Frantz, Joshua A Hirsch

  • Open Access

    Clinical outcomes and independently adjudicated results of M2 aspiration thrombectomy: a subgroup analysis from the Imperative Trial

    by Justin R Mascitelli, Reade Andrew De Leacy, William Mack, Raul Nogueira, Shahram Majidi, Robert Dana Tomalty, Maxim Mokin, Jan Vargas, Brett L Cucchiara, Kenneth V Snyder, et al.

    Background The ESCAPE-MeVO (Endovascular Treatment to Improve Outcomes for Medium Vessel Occlusions) and DISTAL (Endovascular Therapy plus Best Medical Treatment vs Best Medical Treatment Alone for Medium Vessel Occlusion Stroke) trials failed to demonstrate the superiority of endovascular thrombectomy over best medical management for medium and small vessel occlusions. Potential limitations of these trials include older patient populations, lower presenting National Institutes of Health Stroke Scale (NIHSS) scores, higher rates of premorbid disability, delayed revascularization times, inclusion of both medium and small vessel occlusions, and widespread use of stent retrievers. Here we present M2 occlusion data from the Imperative Trial, evaluating aspiration thrombectomy with the Zoom System. Methods The Imperative Trial is a prospective, multicenter, single-arm trial with independent core lab and safety board adjudication, evaluating aspiration thrombectomy with the Zoom System (Imperative Care, Campbell, CA, USA) for large vessel, including M2, occlusions. This subanalysis includes patients with primary M2 occlusions. Angiographic outcomes were defined as modified Treatment in Cerebral Infarction (mTICI) score ≥2b (good) and ≥2c (excellent). Clinical outcomes were defined as modified Rankin Scale score (mRS) 0–2 (good) and 0–1 (excellent) at 90 days. Safety was assessed by all-cause mortality, symptomatic intracranial hemorrhage (sICH), and all hemorrhage. Results Of 260 enrolled patients, 25% (65/260) had primary M2 occlusions. Median age was 69 years; median NIHSS was 13. Good and excellent reperfusion were achieved in 88% (57/65) and 66% (43/65), respectively. At 90 days, good and excellent clinical outcomes occurred in 62% (39/63) and 56% (35/63), respectively. Mortality, sICH, and any hemorrhage were 4.6% (3/65), 1.5% (1/65), and 18% (12/65), respectively. Conclusions The Zoom System demonstrated excellent safety and efficacy in M2 occlusions. These findings support aspiration thrombectomy for M2 occlusions as a viable treatment in well-selected patients.


  • Open Access

    Stroke thrombectomy with a novel reperfusion system including a 0.088′′ aspiration catheter: the Imperative Trial

    by William Mack, Reade Andrew De Leacy, Jonathan A Grossberg, Shahram Majidi, Robert Dana Tomalty, Maxim Mokin, Jan Vargas, Brett L Cucchiara, Kenneth V Snyder, Justin Mascitelli, et al.

    Background Mechanical thrombectomy is the standard of care for large vessel occlusion (LVO) stroke, yet most device trials focus on individual technologies rather than complete systems. Objective To evaluate the safety and efficacy of the Zoom Reperfusion System compared with performance goals derived from a meta-analysis of trials using established thrombectomy technologies. Methods Prospective, multicenter, non-randomized, investigational device exemption trial conducted across 26 United States centers from October 2021 to March 2024. Adults with anterior circulation LVO stroke within 8 hours of onset were treated using the Zoom System, which includes aspiration catheters ranging from 0.035″ to 0.071″, and a novel 0.088″ intracranial guide/aspiration catheter. The primary efficacy endpoint was successful reperfusion (modified Thrombolysis in Cerebral Infarction (mTICI) 2b-3) within three passes using Zoom-only components, adjudicated by an independent core laboratory. The primary safety endpoint was symptomatic intracranial hemorrhage (sICH). Secondary outcomes included final reperfusion, first-pass success, time to reperfusion, 90-day modified Rankin Scale (mRS), and mortality. Results Among 260 patients (median age 68 years; median National Institutes of Health Stroke Scale (NIHSS) 15), successful reperfusion within three passes was achieved in 83% (216/259; 95% CI: 78% to 89%), exceeding the performance goal (pConclusions The Zoom Reperfusion System demonstrated a safety and efficacy profile exceeding prespecified contemporary performance metrics with potential to significantly shorten reperfusion times and reduce the need for rescue therapy. Trial registration number ClinicalTrials.gov--Identifier:NCT04129125.


  • Commentary on the River Stent Trial: Venous Sinus Stenting is Safe and Effective and can be Fully Evaluated Using Noninvasive Methods

    by Matthew Robert Amans, Michael Levitt, Joshua A Hirsch, J Mocco, David Fiorella, David Altschul, Dorothea Altschul, Michael Chen, Reade Andrew De Leacy, Adam S Arthur, et al.